ELV
Elevance Health Inc.
Latest News for ELV
In a report released yesterday, Lance Wilkes from Bernstein assigned a Buy rating to Elevance Health, with a price target of $384.00. The company’s......
In a report released today, Soumit Roy from JonesTrading maintained a Buy rating on Enliven Therapeutics, with a price target of $45.00. According ......
Medicare payments are a big source of revenue for health insurers. ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Diamedica Therapeutics (DMAC), Elevance Health (ELV) and Oric Pha......
Macquarie analyst maintained a Buy rating on Elevra Lithium today and set a price target of A$10.30. Currently, the analyst consensus on Elevra Lit......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $53.00. According to TipRanks, ......
LifeSci Capital analyst Sam Slutsky maintained a Buy rating on Enliven Therapeutics today and set a price target of $53.00. According to TipRanks, ......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioAge Labs, Inc. (BIOA) and Enliven Therapeutics (ELVN). BioAge ......
An update from Elevra Lithium ( ($AU:ELV) ) is now available. Elevra Lithium has completed a small shareholding sale facility aimed at consolidatin......
Elevra Lithium ( ($AU:ELV) ) has issued an update. Elevra Lithium has filed a NI 43-101 compliant technical report supporting its previously releas......
News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 10 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ELV | $316.87 | -0.4% | 1.16M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |